Investors/Analysts call with Management
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
JB Pharma has scheduled a conference call for investors and analysts on Tuesday, May 12, 2026 at 8:30 AM IST to discuss Q4 FY26 results ending March 31, 2026. The financial results will be announced on Monday, May 11, 2026, a day before the call. The company's senior management will be present to address the call. Dial-in numbers are provided for India, Hong Kong, Singapore, UK, and USA. This is a routine regulatory disclosure under SEBI LODR regulations informing about an upcoming earnings call.
No immediate impact on stock price as this is only an announcement of a scheduled call. The actual results and any material developments will be discussed during the May 12 call after the results are released on May 11.